menu
    • menu

    Company profile for SFA Therapeutics

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease-- the use of microbiome-derived metabolites as drugs. Our pipeline includes treatments for Psoriasis, Liver Cancer (Hepatitis B, NASH and HCC), Ophthalmic Diseases, Cytokine Release Syndrome- a side effect in CAR-T, Prevention of Relapse/Recurrence in Leukemias, and oth...
    SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease-- the use of microbiome-derived metabolites as drugs. Our pipeline includes treatments for Psoriasis, Liver Cancer (Hepatitis B, NASH and HCC), Ophthalmic Diseases, Cytokine Release Syndrome- a side effect in CAR-T, Prevention of Relapse/Recurrence in Leukemias, and other diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SFA TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046
    Telephone
    Telephone
    267-584-1080
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sfatherapeutics.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/sfa
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SFA Reports Ph1b Data For SFA-002 In Mild-To-Moderate Psoriasis
    SFA Reports Ph1b Data For SFA-002 In Mild-To-Moderate Psoriasis

    07 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sfa-therapeutics-announces-positive-phase-1b-data-of-sfa-002-in-mild-to-moderate-psoriasis-302395342.html

    PR NEWSWIRE
    07 Mar 2025
    Share Share
    SFA-002 Preclinical Data In Psoriasis Presented At AAD 2025
    SFA-002 Preclinical Data In Psoriasis Presented At AAD 2025

    07 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/head-to-head-preclinical-studies-of-sfa-002-as-a-novel-psoriasis-treatment-presented-at-the-2025-american-academy-of-dermatology-annual-meeting-302395344.html

    PR NEWSWIRE
    07 Mar 2025
    Share Share
    SFA Therapeutics Strengthens IP In Autoimmune Disease And HCC
    SFA Therapeutics Strengthens IP In Autoimmune Disease And HCC

    22 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sfa-therapeutics-strengthens-intellectual-property-in-autoimmune-disease-and-hepatocellular-carcinoma-302282316.html

    PR NEWSWIRE
    22 Oct 2024
    Share Share
    SFA Therapeutics Appoints Dr. Ananda Gubbi as Director of Biostatistics
    SFA Therapeutics Appoints Dr. Ananda Gubbi as Director of Biostatistics

    04 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sfa-therapeutics-appoints-dr-ananda-gubbi-as-director-of-biostatistics-302237111.html

    PR NEWSWIRE
    04 Sep 2024
    Share Share
    SFA Therapeutics Appoints New Chief Operating Officer
    SFA Therapeutics Appoints New Chief Operating Officer

    16 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sfa-therapeutics-strengthens-management-team-with-appointment-of-chief-operating-officer-302194031.html

    PR NEWSWIRE
    16 Jul 2024
    Share Share
    SFA Completes Enrollment For SFA-002 Psoriasis Phase 1b
    SFA Completes Enrollment For SFA-002 Psoriasis Phase 1b

    30 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sfa-therapeutics-announces-completion-of-enrollment-in-phase-1b-trial-of-sfa-002-for-psoriasis-302158420.html

    PR NEWSWIRE
    30 May 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search